Bajaj Healthcare entering into definitive CDMO contract with UK/EU based companies

09 Dec 2024 Evaluate

Bajaj Healthcare is entering into a definitive Contract Development and Manufacturing Organization (CDMO) contract with UK/EU based companies for 15 new active pharmaceutical ingredients (APIs). This is in addition to 15 molecules for which the company entered the contract with UK/EU based clients on February 27, 2024. The new CDMO pipeline has a mix of, off Patent Generic APIs as well as APIs which are still under patent. 

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.


Bajaj Healthcare Share Price

579.15 16.25 (2.89%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...